Credit Suisse Entrepreneur Capital co-led the insulin injection device developer’s latest round, participating alongside investors including Tandem Diabetes Care and Ypsomed.

Switzerland-based insulin delivery service CeQur received $115m on Tuesday in a series C5 round that included medical device producer Tandem Diabetes Care and diabetes injection system provider Ypsomed.

The round was co-led by financial services firm Credit Suisse’s Entrepreneur Capital fund and private equity firm Endeavour Vision and also featured Federated Hermes Kaufmann Funds, GMS Capital, Kingdon Capital Management, Schroder & Co Bank and Venture Incubator (VI Partners).

Spun off by Denmark-headquartered industrial product manufacturer Danfoss in 2008, CeQur is…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn